KROS
Keros Therapeutics Inc.
$12.50
+$0.25(+2.08%)
43
Overall
80
Value
9
Tech
42
Quality
Market Cap
$500.56M
Volume
246.00K
52W Range
$9.12 - $22.55
Target Price
$22.50
EPS Estimates Overview
| Current Quarter | $-1.02 | Next Quarter | $-1.29 |
| Current Year | $-4.99 | Next Year | $-6.21 |
| QoQ Growth | -26.5% | YoY Growth | -24.4% |
| 3Y EPS CAGR | -25.7% | Target Price | $22.50 |
| Consensus | Buy | Upside | +80.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KROS | $12.50 | +2.1% | 246.00K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |